InvestorsHub Logo
Followers 32
Posts 2812
Boards Moderated 3
Alias Born 10/24/2015

Re: None

Wednesday, 03/23/2022 5:40:59 PM

Wednesday, March 23, 2022 5:40:59 PM

Post# of 29
The PhI (n=54) of LYL797 has now been listed. The dose-escalation phase (TNBC only) will investigate four dose levels to determine the recommended RP2D. The dose expansion will enroll both TNBC and NSCLC.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent LYEL News